This biotech aims to cure Alzheimer's by targeting gum-disease bacteria

This biotech aims to cure Alzheimer's by targeting gum-disease bacteria

STAT Plus: An old idea that’s gaining new traction: curing Alzheimer’s by killing gum-disease bacteria

By SHARON BEGLEY

CORTEXYME

Cortexyme is betting that an infectious agent causes Alzheimer’s, and that targeting that pathogen can stop and even reverse the disease.

READ MORE